Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.

Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.

Item
http://www.wikidata.org/entity/Q46632226
Pharmacological Properties of Bivalent Ligands Containing Butorphan Linked to Nalbuphine, Naltrexone, and Naloxone at μ, δ, and κ Opioid ReceptorsBi- or multifunctional opioid peptide drugs.In vivo characterization of (-)(-)MCL-144 and (+)(-)MCL-193: isomeric, bivalent ligands with mu/kappa agonist propertiesA novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia.Pharmacological Profiles of Oligomerized μ-Opioid Receptors.Opioid receptor targeting ligands for pain management: a review and update.Effect of linker substitution on the binding of butorphan univalent and bivalent ligands to opioid receptorsRapid access to morphinones: removal of 4, 5-ether bridge with Pd-catalyzed triflate reduction.Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administratioSynthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors.[6,7]-heterocycle-fused 14-hydroxymorphinan derivatives: design, synthesis, and opioid receptor activity.
P2860

Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.

Item
http://www.wikidata.org/entity/Q46632226
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Characterization of a novel bi ...... agonist/antagonist properties.
@en
Characterization of a novel bi ...... agonist/antagonist properties.
@nl
type
label
Characterization of a novel bi ...... agonist/antagonist properties.
@en
Characterization of a novel bi ...... agonist/antagonist properties.
@nl
prefLabel
Characterization of a novel bi ...... agonist/antagonist properties.
@en
Characterization of a novel bi ...... agonist/antagonist properties.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Characterization of a novel bi ...... agonist/antagonist properties
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698